Ting‐Qing Gan

743 total citations
30 papers, 578 citations indexed

About

Ting‐Qing Gan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ting‐Qing Gan has authored 30 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ting‐Qing Gan's work include Cancer-related molecular mechanisms research (21 papers), MicroRNA in disease regulation (16 papers) and RNA modifications and cancer (11 papers). Ting‐Qing Gan is often cited by papers focused on Cancer-related molecular mechanisms research (21 papers), MicroRNA in disease regulation (16 papers) and RNA modifications and cancer (11 papers). Ting‐Qing Gan collaborates with scholars based in China. Ting‐Qing Gan's co-authors include Gang Chen, Rong‐Quan He, Zu-yun Li, Ruixue Tang, Li‐Hua Yang, Wenjie Chen, Dianzhong Luo, Yu Zhang, Kang‐Lai Wei and You Xie and has published in prestigious journals such as Scientific Reports, Respiratory Research and Cellular Physiology and Biochemistry.

In The Last Decade

Ting‐Qing Gan

30 papers receiving 574 citations

Peers

Ting‐Qing Gan
Liyun Luo China
Chengcheng Ren China
Dong‐Qiu Dai China
Pengwei Lv China
Kei Ihira Japan
Fu‐Chun Huo China
Yi Zang China
Gloria Ros Italy
Junqing Hou China
Liyun Luo China
Ting‐Qing Gan
Citations per year, relative to Ting‐Qing Gan Ting‐Qing Gan (= 1×) peers Liyun Luo

Countries citing papers authored by Ting‐Qing Gan

Since Specialization
Citations

This map shows the geographic impact of Ting‐Qing Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting‐Qing Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting‐Qing Gan more than expected).

Fields of papers citing papers by Ting‐Qing Gan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting‐Qing Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting‐Qing Gan. The network helps show where Ting‐Qing Gan may publish in the future.

Co-authorship network of co-authors of Ting‐Qing Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Ting‐Qing Gan. A scholar is included among the top collaborators of Ting‐Qing Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting‐Qing Gan. Ting‐Qing Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Yu-Lu, Guosheng Li, Dongming Li, et al.. (2022). The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer. BMC Pulmonary Medicine. 22(1). 300–300. 7 indexed citations
2.
Li, Guosheng, et al.. (2021). Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma. Mathematical Biosciences & Engineering. 18(5). 6941–6960. 3 indexed citations
3.
Huang, Shuping, Yifan Jiang, Linjie Yang, et al.. (2020). Downregulation of miR-125b-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 37(2). 125–140. 6 indexed citations
4.
Li, Zu-yun, Ting‐Qing Gan, Ye‐Ying Fang, et al.. (2020). Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses. Respiratory Research. 21(1). 60–60. 12 indexed citations
5.
Yang, Daping, Wan‐Ying Huang, Gang Chen, et al.. (2020). Clinical significance of transcription factor RUNX2 in lung adenocarcinoma and its latent transcriptional regulating mechanism. Computational Biology and Chemistry. 89. 107383–107383. 12 indexed citations
6.
7.
Zou, Xiaoping, Xin‐Gan Qin, Rong‐Quan He, et al.. (2018). Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map. Molecular Medicine Reports. 19(2). 1004–1015. 4 indexed citations
8.
Tan, Lin, et al.. (2018). EBV as a potential risk factor for hepatobiliary system cancer: A meta-analysis with 918 cases. Pathology - Research and Practice. 215(2). 278–285. 8 indexed citations
9.
Zhang, Tong-Tong, Yuan Qin, Ting‐Qing Gan, et al.. (2018). Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis. World Journal of Surgical Oncology. 16(1). 109–109. 18 indexed citations
10.
Luo, Jie, Ke Shi, Shuya Yin, et al.. (2018). Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation. World Journal of Surgical Oncology. 16(1). 76–76. 26 indexed citations
11.
12.
Chen, Wenjie, Ting‐Qing Gan, Hui Qin, et al.. (2017). Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma. Pathology - Research and Practice. 213(4). 364–372. 26 indexed citations
13.
Zhang, Yu, Wenjie Chen, Ting‐Qing Gan, et al.. (2017). Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification. Scientific Reports. 7(1). 5567–5567. 44 indexed citations
14.
Huang, Wenting, Rong‐Quan He, You Xie, et al.. (2017). Effect of miR-146a-5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation. Molecular Medicine Reports. 16(6). 8781–8792. 13 indexed citations
15.
Zhang, Yu, Rong‐Quan He, Yiwu Dang, et al.. (2016). Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells. Cancer Cell International. 16(1). 89–89. 55 indexed citations
16.
Zhang, Xin, Wei Tang, Ruishan Li, et al.. (2016). Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma. Experimental and Therapeutic Medicine. 12(4). 2095–2101. 28 indexed citations
17.
Wei, Kang‐Lai, Zhihua Ye, Zu-yun Li, et al.. (2015). An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker. World Journal of Surgical Oncology. 14(1). 34–34. 26 indexed citations
18.
Li, Zu-yun, et al.. (2015). Expression and clinical contribution of MRGD mRNA in non-small cell lung cancers.. PubMed. 20(4). 1101–6. 4 indexed citations
19.
Gan, Ting‐Qing, Ruixue Tang, Rong‐Quan He, et al.. (2015). Upregulated MiR-1269 in hepatocellular carcinoma and its clinical significance.. PubMed. 8(1). 714–21. 33 indexed citations
20.
Cai, Xiaoyong, et al.. (2013). Meta-analysis of the association of glutathione S-transferase T1 null/presence gene polymorphism with the risk of gastric carcinoma. Molecular Biology Reports. 41(2). 639–649. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liyun Luo Breakdown of academic impact, for papers by Chengcheng Ren Breakdown of academic impact, for papers by Dong‐Qiu Dai Breakdown of academic impact, for papers by Pengwei Lv Breakdown of academic impact, for papers by Kei Ihira Breakdown of academic impact, for papers by Fu‐Chun Huo Breakdown of academic impact, for papers by Yi Zang Breakdown of academic impact, for papers by Gloria Ros Breakdown of academic impact, for papers by Junqing Hou
Rankless by CCL
2026